Abstract
Background:
Hospitalized patients with acute medical conditions have higher venous thromboembolism (VTE) risk. A patient with a final Padua Prediction Score (PPS) of ≥4 is considered to be at high risk for VTE. The aim of this study was to investigate on a possible relationship between PPS, the dynamics of the clot formation, i.e. the clot waveform analysis (CWA) of aPTT, fibrinogen and D-Dimer in a large group of medical patients.
Methods:
CWA in terms of velocity (first derivative), acceleration (second derivative), density (Delta) of aPTT, fibrinogen, D-Dimer and PPS for VTE were determined in 801 medical patients divided in three groups (without antithrombotic prophylaxis and high PPS, without antithrombotic prophylaxis and low PPS, with antithrombotic prophylaxis and high PPS) and a group of healthy subjects.
Results:
CWA, fibrinogen and D-Dimer values were higher in the medical patients with high PPS with or without antithrombotic prophylaxis when compared with patients without antithrombotic prophylaxis with low PPS and healthy subjects. The second derivative, fibrinogen and D-Dimer were significantly associated with a high PPS score (≥4): odds ratio (OR) = 1.53, 95% confidence interval (CI) = 1.03–2.28; OR = 1.91, 95% CI = 1.3–2.79; OR = 3.16, 95% CI = 2.29–4.36, respectively. Interactions between first derivative and D-Dimer (OR = 2.14, 95% CI = 1.23–3.72) and first derivative and fibrinogen (OR = 1.75, 95% CI = 1.02–2.98) were found.
Conclusions:
CWA could give useful information to recognize a hypercoagulable state in patients admitted to a medical ward with high and low PPS. First and second derivative aPTT, D-Dimer and fibrinogen levels could be added to PPS to better assess the global thromboembolic risk of these patients.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Prandoni P, Samama MM. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients. Br J Haematol 2008;141:587–97.10.1111/j.1365-2141.2008.07089.xSearch in Google Scholar PubMed
2. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141:e195S–226.10.1378/chest.11-2296Search in Google Scholar PubMed PubMed Central
3. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010;8:2450–57.10.1111/j.1538-7836.2010.04044.xSearch in Google Scholar PubMed
4. Braun PJ, Givens TB, Stead AG, Beck LR, Gooch SA, Swan RJ, et al. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemost 1997;78:1079–87.10.1055/s-0038-1657690Search in Google Scholar
5. Solano C, Zerafa P, Bird R. A study of atypical APTT derivative curves on the ACL TOP coagulation analyser. Int J Lab Hematol 2011;33:67–78.10.1111/j.1751-553X.2010.01248.xSearch in Google Scholar PubMed
6. Shima M, Thachil J, Nair SC, Srivastava A, Scientific and standardization committee. Towards standardization of clot waveform analysis and recommendations for its clinical applications. J Thromb Haemost 2013;11:1417–20.10.1111/jth.12287Search in Google Scholar PubMed
7. Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J 2015;13:1.10.1186/1477-9560-13-1Search in Google Scholar PubMed PubMed Central
8. Siegemund T, Scholz U, Schobess R, Siegemund A. Clot waveform analysis in patients with haemophilia A. Haemostaseologie Supplement 2014;34:S48–62.10.5482/HAMO-14-02-0016Search in Google Scholar PubMed
9. Vardi M, Ghanem-Zoubi NO, Zidan R, Yurin V, Bitterman H. Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments. J Thromb Haemost 2013;11:467–73.10.1111/jth.12108Search in Google Scholar PubMed
10. Downey C, Kazmi R, Toh CH. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis. Thromb Haemost 1998;80:65–9.10.1055/s-0037-1615140Search in Google Scholar
11. Ruberto MF, Sorbello O, Civolani A, Barcellona D, Demelia L, Marongiu F. Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena. Int J Lab Hematol 2017;39:369–74.10.1111/ijlh.12635Search in Google Scholar PubMed
12. Olson JD. D-dimer: an overview of hemostasis and fibrinolysis, assays, and clinical applications. Adv Clin Chem 2015;69:1–46.10.1016/bs.acc.2014.12.001Search in Google Scholar PubMed
13. Traby L, Kaider A, Schmid R, Kranz A, Quehenberger P, Kyrle PA, et al. The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trial. Thromb Haemost 2010;104:92–9.10.1160/TH09-12-0863Search in Google Scholar PubMed
14. Marongiu F, Conti M, Mameli G, Murtas ML, Balzano S, Sorano G, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 1988;11:723–5.10.1007/BF03350928Search in Google Scholar PubMed
15. Marongiu F, Conti M, Mameli G, Sorano GG, Cirillo R, Balestrieri A. “Falsely increased” B beta 15-42 levels in diabetes. Diabetes Care 1990;13:1129–30.10.2337/diacare.13.11.1129Search in Google Scholar PubMed
16. Marongiu F, Mameli G, Acca MR, Mulas G, Medda A, Tronci MB, et al. Fibrinopeptide A and B beta 15-42 in liver cirrhosis. Haemostasis 1988;18:126–28.Search in Google Scholar
17. Marongiu F, Biondi G, Conti M, Murtas ML, Mameli G, Sorano GG, et al. Is a hypercoagulable state present in hypothyroidism? Thromb Haemost 1992;67:729.10.1055/s-0038-1648535Search in Google Scholar
18. Palareti G. D-Dimer testing in patients with a first unprovoked venous thromboembolism. Ann Intern Med 2015;162:670–71.10.7326/L15-5089Search in Google Scholar PubMed
19. Bjøri E, Johnsen HS, Hansen JB, Braekkan SK. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence. J Thromb Haemost 2017;15:917–24.10.1111/jth.13648Search in Google Scholar PubMed
20. Chatterjee MS, Denney WS, Jing H, Diamond SL. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 2010; doi: 10.1371/journal.pcbi.1000950.10.1371/journal.pcbi.1000950Search in Google Scholar PubMed PubMed Central
©2018 Walter de Gruyter GmbH, Berlin/Boston
